Research at Regional Center Vienna
RCV is the regional affiliate of Boehringer Ingelheim and responsible for over 30 countries in Central and Eastern Europe and Central Asia.
Search
Science Focus
Our Science Focus at Boehringer Ingelheim
Our Responsibility
Human Health Our Responsibility
Boehringer Ingelheim Awards Innovation Prize to Ablevia
Innovative solution from Ablevia for rapid and selective elimination of harmful antibodies without impediment to the immune system
Boehringer Ingelheim’s Postdoctoral Program
Boehringer Ingelheim’s postdoctoral program in Regional Center Vienna (RCV) provides scientists with the opportunity to pursue research.
Obesity
Obesity
Partnering
We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Fostering innovation with partnerships and collaborations
Creating new and better medicines for patients. This commitment is driven by a strong belief in the power of collaboration.
Embracing diversity in clinical trials: A global mandate
Have you ever wondered why medicines work differently for different people? Each patient is unique. By embracing diversity in clinical trials, we enable more equitable and inclusive healthcare.
Clinical Studies
Clinical Studies
Science Stories
Science Stories
Animal Health Innovation
Animal Health Innovation
Women Leaders Network: Success is Female
Powerful teams are very often diverse. A good mixture of different personalities is beneficial, and it is for this reason that diversity in general has been encouraged for years at Boehringer Ingelheim.
Improving Access to Healthcare
According to the UN Sustainable Development Goals, nearly half of the world's population lacks access to basic health care.
Grass Roots
Grass Roots
Sustainable Development
Sustainable Development
Corporate Profile
Corporate Profile
The global $1 trillion mental health problem needs more funding
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
Our Commitment
Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.
COPD
COPD
Stroke
Stroke
Skin Diseases
Skin Diseases | We discover and develop breakthrough therapies that can be used to prevent, treat and repair many inflammatory and fibrotic diseases.
Patient Safety & Pharmacovigilance at Boehringer Ingelheim
Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.
Mental Health
Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Data Privacy-video surveillance at Boehringer Ingelheim
Data Protection Notice for video surveillance